Alternatively, are deep intronic variants or changes in the regulatory (promoter, enhancer) regions of the already known ENG, ACVRL1/ALK1, MADH4, and BMP9 genes responsible for HHT, which accounts for the percentage of genetically undiagnosed patients? The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.